SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Senetek (SNTK)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: SemiBull who wrote (44)9/19/2003 8:51:25 PM
From: SemiBull   of 101
 
Senetek PLC Launches kinetinplus.com Web Site

Friday September 19, 12:18 pm ET

NAPA, Calif., Sept. 19 /PRNewswire-FirstCall/ -- Senetek PLC (Nasdaq: SNTK - News), www.senetekplc.com , a biopharmaceutical company focused on developing and marketing products that meet under-met consumer needs for aging well, today announced that it has launched an interactive Web site for the direct purchase of its new, full Kinetin Plus line at kinetinplus.com .

The Web site brings interested consumers complete information about Kinetin, including data from clinical studies conducted at a prestigious university, and scientific photographs of the results of the 48-week study. The site allows interested consumers to enroll in the Kinetin Plus(TM) "Looking Good Feels Good" program and offers for sale eight Kinetin Plus(TM) products. The site was developed in conjunction with the Company's new infomercial for Kinetin Plus(TM), which recently completed a pilot media test schedule.

Senetek's patented ingredient, Kinetin, is a naturally occurring cytokinin that has proven to be effective in treating the appearance of aging skin with minimal side effects. Senetek's eleven current Kinetin licensees include ICN Pharmaceuticals, Inc., Revlon, Inc. and The Body Shop, which have successfully introduced Kinetin in their respective channels of distribution. The infomercial and new Web site are Senetek's first channels for selling its popular Kinetin products directly to consumers.

Visit Senetek PLC's Web site: senetekplc.com .

Senetek PLC Investor Relations Contact:
1-707-226-3900 ext. 102
E-Mail: Pknopick@eandecommunications.com

Safe Harbor Statement:

This news release may contain statements that may be considered "forward-looking statements" under the federal securities laws, including statements concerning the eventual national roll-out of the infomercial, the potential success of the Kinetin Plus product line and the hoped-for benefits of this product launch. Forward-looking statements by their nature involve substantial uncertainty and there can be no assurance that actual results or events will not differ materially from those described in the forward-looking statements as a result of various factors, including the risks and uncertainties described in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2002 and Quarterly Reports on Form 10-Q for subsequent calendar quarters of 2003, filed with the Securities and Exchange Commission. In addition, while the Company has attempted to identify in those filings the principal factors that it believes could result in such material differences, there can be no assurance that it has identified all of such factors or all of the ways in which such factors may affect future results or events.

Source: Senetek PLC
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext